Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group
Resource Type
Article
Authors
Le Gouill, Steven ; Beldi-Ferchiou, Asma ; Alcantara, Marion ; Cacheux, Victoria ; Safar, Violaine ; Burroni, Barbara ; Guidez, Stéphanie ; Gastinne, Thomas ; Canioni, Danielle ; Thieblemont, Catherine ; Maisonneuve, Hervé ; Bodet-Milin, Caroline ; Houot, Roch ; Oberic, Lucie ; Bouabdallah, Krimo ; Bescond, Charles ; Damaj, Ghandi ; Jaccard, Arnaud ; Daguindau, Nicolas ; Moreau, Anne ; Tilly, Hervé ; Ribrag, Vincent ; Delfau-Larue, Marie-Hélène ; Hermine, Olivier ; Macintyre, Elizabeth
Source
In The Lancet Haematology November 2020 7(11):e798-e807
Subject
Primary Research Articles
Language
ISSN
2352-3026